ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693167 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693167; 2) Community: the network communities that were significantly associated with the response to NSC 693167; 3) Molecule: the relationships between components within communities and NSC 693167; 4) MDR: the compounds that were significantly associated with the NSC 693167.

NSC Compound Enrichment Correlation
NSC 674067 stereoisomer of NSC 674066-O 0.0304779558345021 0.18996064
NSC 677945 Quinoline-5,8-dione, 6-[(3-hydroxy-3-phenyl-2-propyl)amino]- 0.0304779558345021 0.14091489
NSC 678125 1H-indazole, 3-methoxy-1-[(2-methoxyphenyl)methyl]- 5-nitro- 0.0366216145653018 0.10475645
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0386895225700407 0.22557792
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0386895225700407 0.24983294
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0386895225700407 0.39317209
NSC 169774 Bromocriptine methanesulfonate 0.0386895225700407 0.17318584
NSC 195327 4-APPT 0.0386895225700407 0.27357018
NSC 295501 Camptothecin Derivative 0.0386895225700407 0.4433445
NSC 308847 Amonafide 0.0386895225700407 0.34453224
Total:47  Current:36    [First] [Prev] [Next] [Last]